Specifically, we contrast the outcomes of four distinct mobilization regimens: Cy+PEG G-CSF+/-PXF, Cy+PEG G-CSF, Cy+G-CSF, and G-CSF+PXF, all administered to MM patients poised for ASCT. Here, CSF3 is linked to Miyoshi myopathy.